페프로민바이오
Irvine, US · 1 known investors
Find your way into 페프로민바이오
PeproMene Bio develops platform and products targeting BAFF-R, an innovative tumor antigen for treating B cell malignancies and autoimmune diseases. The company focuses on immune therapies to address tumor relapse caused by antigen loss in patients with unmet medical needs.
Founders & leadership
NH
Nicolas HwangChief Executive Officer
AP
Andrew ParkChief Financial Officer
Investors · 1
Competitors · 3
by search overlapBuiltinla12 shared keywordsBlock, Inc. operates a suite of financial services and technology brands including payment processing, cash transfer, music streaming, and bitcoin products. The company serves sellers, consumers, artists, and bitcoin users globally to expand access to financial systems.
Orange County Business Council9 shared keywordsA promotional page for Orange County, California, describing the region's industries, lifestyle, weather, and economic resources to attract companies. It is a location/economic development marketing site rather than a startup or product company.
Amberstone Biosciences9 shared keywords
Companies competing with 페프로민바이오 for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does 페프로민바이오 do?
- PeproMene Bio develops platform and products targeting BAFF-R, an innovative tumor antigen for treating B cell malignancies and autoimmune diseases. The company focuses on immune therapies to address tumor relapse caused by antigen loss in patients with unmet medical needs.
- Who are 페프로민바이오's investors?
- 페프로민바이오's investors include Solidus Investment.
- Where is 페프로민바이오 headquartered?
- 페프로민바이오 is headquartered in Irvine, US.
